Linking Infectious and Narcology Care-Part II

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions
HIV InfectionDrug Use
Interventions
OTHER

Rapid ART initiation

The infectionist will streamline the approval with the ultimate goal of starting participants on ART while they are still hospitalized at the City Addiction Hospital.

DRUG

Pharmacotherapy for opioid use disorder

Thirteen months of naltrexone treatment for opioid use disorder (injection at baseline, followed by 4 implants).

BEHAVIORAL

Strengths-based HIV case management

Strengths-based case management: 10 sessions over 12 months in which a trained case manager (CM) meets individually with patients to motivate them to engage in HIV medical care by supporting the recognition of their own strengths to make positive changes in their lives and ultimately improve their HIV outcomes.

Trial Locations (2)

197022

First St. Petersburg Pavlov State Medical University, Saint Petersburg

Unknown

City Addiction Hospital, Saint Petersburg

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Boston Medical Center

OTHER

NCT03290391 - Linking Infectious and Narcology Care-Part II | Biotech Hunter | Biotech Hunter